1999
DOI: 10.1046/j.1440-1754.1999.00349.x
|View full text |Cite
|
Sign up to set email alerts
|

Changing mortality and causes of death in infants 23-27 weeks' gestational age

Abstract: As the mortality rate has fallen over time, respiratory causes of death have diminished, but septic causes of death have increased. Further advances in the use of exogenous surfactant and respiratory support may reduce respiratory deaths. Effective strategies to reduce nosocomial infections are urgently required.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
18
0
2

Year Published

2003
2003
2021
2021

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 43 publications
(24 citation statements)
references
References 6 publications
4
18
0
2
Order By: Relevance
“…In the present study, the outcome was better in patients with gestational age above 30 weeks and this was statistically significant (p = 0.035). Outcome according to birth weight was also better amongst patients with birth weight greater than 2000 g. Other studies corroborate this finding to this fact [27] [28] [29]. The mortality was quite high in our study 27 (28.4%) …”
Section: Discussionsupporting
confidence: 90%
“…In the present study, the outcome was better in patients with gestational age above 30 weeks and this was statistically significant (p = 0.035). Outcome according to birth weight was also better amongst patients with birth weight greater than 2000 g. Other studies corroborate this finding to this fact [27] [28] [29]. The mortality was quite high in our study 27 (28.4%) …”
Section: Discussionsupporting
confidence: 90%
“…Circulatory failure is responsible for a high proportion of neonatal mortality,2 particularly when associated with sepsis, and is implicated in the pathogenesis of neonatal cerebral3 and pulmonary injury 4…”
mentioning
confidence: 99%
“…In addition, surfactant could be inactivated by oxygen radicals and enzymes. 16,[18][19][20] Further study is needed to evaluate the efficacy of administering surfactant to neonates who experience secondary respiratory failure after recuperation from their initial respiratory distress.…”
Section: Discussionmentioning
confidence: 99%